P28.02 Beyond PACIFIC: Outcomes and Toxicity According to Durvalumab Dosing Schedule Every 2 versus 4 Weeks
| Autor: | Denault, M., Kuang, S., Shokoohi, A., Leung, B., Liu, M., Laskin, J., Zhang, T., Melosky, B., Ho, C., Berthelet, E., Sun, S. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology October 2021 16(10) Supplement:S1044-S1045 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|